Doctors discuss safety and long-term use of Ozempic for weight loss

Ozempic, a diabetes medication, is widely recognized for its weight loss effects, although it is not officially approved for this purpose. It shares the same active ingredient, semaglutide, with Wegovy, which is approved for weight management. Insurance coverage for Ozempic for weight loss is limited. Doctors express concerns about long-term safety and potential side effects, including thyroid tumors and pancreatitis. While some studies suggest benefits for obesity-related health issues, the long-term effects of semaglutide are still being evaluated. Experts indicate that semaglutide may require lifelong use for effective weight management, similar to treatments for chronic conditions like high blood pressure. Ongoing monitoring and reassessment by healthcare providers are recommended for patients using these medications.